Groove Botanicals Q1 FY2027: Going Concern Warning, $1,494 Cash, Material Weakness
GRVE has more than doubled off its 52-week low of $0.001 on elevated volume (2.4× avg).
Summary
Groove Botanicals' Q1 FY2027 10-Q shows a company with $1,494 in cash, zero revenue, a going concern warning, and a material weakness in internal controls. The sole officer/director is funding operations via related-party advances, and the company has no clear path to raising the capital it needs.
Key Events · Earnings and Guidance · GRVE
-
Going Concern Warning
Auditor raises substantial doubt about the company's ability to continue as a going concern, citing recurring losses, $35.6M accumulated deficit, and only $1,494 in cash.
-
Zero Revenue, Mounting Losses
The company reported no revenue for Q1 FY2027, a net loss of $21,171, and a net loss attributable to common shareholders of $75,789 after preferred dividends.
-
Material Weakness in Internal Controls
Disclosure controls and procedures are ineffective due to a lack of segregation of duties (one person serves as CEO/CFO) and no formal audit committee.
-
Related-Party Dependence
The company is funded entirely by advances from CEO Kent Rodriguez, with related-party payables of $774,140 and accrued dividends of $710,028. Rodriguez controls 51% of voting power.
Analysis · GRVE · Energy & Transportation
Groove Botanicals' Q1 FY2027 10-Q reveals a company in severe distress. With only $1,494 in cash, zero revenue, and an accumulated deficit of $35.6 million, the auditor's going concern warning is stark. The company is being kept alive by related-party advances from its sole officer, Kent Rodriguez, who controls 51% of voting power through Series A preferred stock. A material weakness in internal controls — no segregation of duties and no audit committee — adds governance risk. The recent auditor change, disclosed in the filing, further clouds the picture. The company's plan to pivot to Norwegian tech licensing is aspirational but unfunded, with capital needs estimated at $500,000 to $5 million. This is a penny stock (trading at $0.0041) with a market cap of just $244,537, and the financials confirm it is essentially a shell with no operations, mounting liabilities, and no clear path to funding.
At the time of this filing, GRVE was trading at $0.00 on OTC in the Energy & Transportation sector, with a market capitalization of approximately $244.5K. The 52-week trading range was $0.00 to $0.30. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.